Module 1: Overview of HIV Infection Module 3: Overview of HIV Testing Technologies

Similar documents
Suggested Reporting Language for the HIV Laboratory Diagnostic Testing Algorithm

HIV DIAGNOSIS: A GUIDE FOR SELECTING RAPID DIAGNOSTIC TEST (RDT) KITS

Evaluation of Diagnostic and Screening Tests: Validity and Reliability. Sukon Kanchanaraksa, PhD Johns Hopkins University

Types of HIV test. Antigen - Any substance (such as an immunogen or a hapten) foreign to the body that stimulates an immune system response.

Diagnosis of HIV-1 Infection. Estelle Piwowar-Manning HPTN Central Laboratory The Johns Hopkins University

Online EFFECTIVE AS OF JANUARY 2013

INTERPRETATION INFORMATION SHEET

To help you understand the role documents and records play in the quality system and the monitoring of programs.

Module 5: Assuring the Quality of HIV Rapid Testing

Module 10: Inventory Managing Stocks at the HIV Rapid Testing Site

BVD qpcr Bulk Milk Test

Philadelphia University Faculty of Information Technology Department of Computer Science --- Semester, 2007/2008. Course Syllabus

Module 5 Laboratory CONTENTS ILLUSTRATED GUIDES

Specimen and Data Repository for TB Diagnostic Research in Children. Sharon Nachman SUNY Stony Brook

Overview of CLIA-Waived Rapid HIV Tests and the HIV Rapid

Global Fund Quality Assurance for Diagnostics

Reliability Applications (Independence and Bayes Rule)

Changing Concept of FMD diagnostics: from Central to Local. Aniket Sanyal Project Directorate on FMD Mukteswar, India

Algorithm for detecting Zika virus (ZIKV) 1

LYME DISEASE. 2.5M specimen tests per year. 97% accuracy with Rockland tools

Bayes Theorem & Diagnostic Tests Screening Tests

HIV ASSAYS: OPERATIONAL CHARACTERISTICS

2 Session Two - Complex Numbers and Vectors

Hepatitis and Retrovirus. LIAISON XL Accurate detection of HIV infection. HIV Ab/Ag FOR OUTSIDE THE US AND CANADA ONLY

Quality Assurance Guidelines for Testing Using Rapid HIV Antibody Tests Waived Under the Clinical Laboratory Improvement Amendments of 1988

Guidelines for TB Blood Testing. Minnesota Department of Health TB Prevention and Control Program June 2011

The Impact of HIV/AIDS on the South African Mining Industry

Preamble: Explaining the Technical Aspects of HIV Testing

VS Guidance Date 04/26/13

Direct Antiglobulin Test (DAT)

Tuberculosis and HIV/AIDS Co-Infection: Epidemiology and Public Health Challenges

ABORhCard Applications and Performance Studies White Paper

Introduction. The Quine-McCluskey Method Handout 5 January 21, CSEE E6861y Prof. Steven Nowick

hp calculators HP 17bII+ Net Present Value and Internal Rate of Return Cash Flow Zero A Series of Cash Flows What Net Present Value Is

Principles of Hypothesis Testing for Public Health

6. MEASURING EFFECTS OVERVIEW CHOOSE APPROPRIATE METRICS

Tuberculosis: FAQs. What is the difference between latent TB infection and TB disease?

Diagnosis and Treatment Regimes for Syphilis By Dr John Bannister

Board of Member States ERN implementation strategies

Biomedical Engineering for Global Health. Lecture Thirteen

LIAISON XL HBsAg Quant

Report. Evaluation of lay-persons ability to use ELDONCARD IDENTITY KIT. This study was performed in collaboration between

Bluetooth Installation

3.2 Conditional Probability and Independent Events

WHO/HIVRESNET HIV DRUG RESISTANCE LABORATORY STRATEGY

HIV SIMPLE/RAPID ASSAYS: OPERATIONAL CHARACTERISTICS

LIAISON XL HCV Ab Accurate diagnosis of the early stage of HCV infection

Project Management and Budgeting for Communicators MPPR Office hours: By appointment and before class

GLOBAL FUND QUALITY ASSURANCE POLICY FOR DIAGNOSTICS PRODUCTS. (Issued on 14 December 2010, amended on 5 February 2014)

Fundamentals of Probability

Finding the Measure of Segments Examples

510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY

MICROPROCESSOR AND MICROCOMPUTER BASICS

Q1 What is systems development?

ABB Drive Services Your choice, your future

Diagnostic Testing Considerations for Shelters and Rescues Part One: Fundamentals

Personal Development Plan. For. Date

Measures of diagnostic accuracy: basic definitions

REI Pearls: Pitfalls of Genetic Testing in Miscarriage

MALARIA DIAGNOSIS: A GUIDE FOR SELECTING RAPID DIAGNOSTIC TEST (RDT) KITS - 1 st edition

DHAPP SENEGAL BACKGROUND. Country Statistics

Quotient Rings and Field Extensions

in hiv diagnostics the role of phls

Direct Testing Systems and Serology

Development and Validation of In Vitro Diagnostic Tests. YC Lee, Ph.D. CEO

Background Information

Preface. TTY: (888) or Hepatitis C Counseling and Testing, contact: 800-CDC-INFO ( )

Content Sheet 7-1: Overview of Quality Control for Quantitative Tests

Mathematics Second Practice Test 1 Levels 4-6 Calculator not allowed

EPIDEMIOLOGY OF HEPATITIS B IN IRELAND

Content. Introduction: Health in Zimbabwe. PSM Zimbabwe. Pag 3. Pag 4. Zimbabwe s Response: Key Achievements. Pag 5

AN SMSC Design Guide for Power Over Ethernet Applications. 1 Introduction. 1.1 Power Over Ethernet

Toxoplasma gondii IgM ELISA Kit Protocol

TTT s : Test and Treat Tracking System on ResearchKit of HIV Carriers in Thailand

Section 5-3 Binomial Probability Distributions

Comparing Methods to Identify Defect Reports in a Change Management Database

Guidebook for Implementation of Laboratory Information Systems in Resource-Poor Settings

Chemistry B11 Chapter 4 Chemical reactions

Direct Antiglobulin Test (DAT)

L 2 : x = s + 1, y = s, z = 4s Suppose that C has coordinates (x, y, z). Then from the vector equality AC = BD, one has

GRANTS IN GOVERNMENT Presented by: Michael Langton, GPC President, Langton Associates 4830 Atlantic Blvd. Jacksonville, Florida (904)

4. Understanding Clinical Data and Workflow Understanding Surveillance Data Exchange Processes Guide and Worksheet

Module 4: Formulating M&E Questions and Indicators

The Louisiana Public Health Information Exchange

Review of Fundamental Mathematics

Offering Testing for Hepatitis B and C in Primary Care

Data Management. Norio Yamada, RIT

DOLBY SR-D DIGITAL. by JOHN F ALLEN

HIV Rapid Test Kits USAID Approval and Technical Guidance June 17, 2013 Revision

The Global Fund experience on malaria RDTs. Rationale to enhance harmonization

LAB 14 ENZYME LINKED IMMUNOSORBENT ASSAY (ELISA)

2 SYSTEM DESCRIPTION TECHNIQUES

What is HIV? What is AIDS? The HIV pandemic HIV transmission Window period Stages of HIV infection

Routine HIV Monitoring

RISK MANAGEMENT SOFTWARE PACKAGES SOLUTION FOR PERFORMANCE ASSESSMENT

Hindrik Vondeling Department of Health Economics University of Southern Denmark Odense, Denmark

OraQuick In-Home HIV Test. Final Advisory Committee Briefing Materials: Available for Public Release. Briefing Document

Quality Improvement Process Using Plan, Do, Study, Act (PDSA) Planning for Action

Implementation of Routine HIV Testing in Health Care Settings: Issues for Community Health Centers

PPS UNDERWRITING GUIDE FOR APPLICANTS

Transcription:

Module 4 HIV Testing Strategies and Algorithms Purpose Pre-requisite Modules Learning Objectives Content Outline Handouts Notes on Customization To provide the participants with a basic understanding of how HIV rapid tests are selected for the country s algorithm and how HIV status is determined following the algorithm. Module 1: Overview of HIV Infection Module 3: Overview of HIV Testing Technologies At the end of this module, you will be able to: Discuss the process for developing a national testing algorithm Explain how sensitivity, specificity, positive/negative predictive value relate to development of an HIV rapid testing algorithm Explain the HIV rapid testing algorithm approved in your country Determine HIV status following a particular algorithm Testing strategies and algorithms Developing national testing algorithm Measuring performance of HIV rapid tests Interpreting HIV status Exercise #1: Interpreting HIV Status Using Testing Algorithm Exercise #2: Interpreting HIV Status Using Testing Algorithm Specify specific tests used in your country algorithm. Delete examples of HIV rapid tests not used in your country s algorithm and replace with in-country examples. Replace testing algorithm diagram with country-specific algorithm. Module 4: HIV Testing Strategies and Algorithms 1 Participant Manual

Strategies and Algorithms Strategies are defined as the testing approach used to meet a specific need, such as for blood safety, surveillance, and diagnosis. For a given strategy, multiple algorithms may be used depending on the needs of testing settings. Algorithms are defined as the combination and sequence of specific tests used in a given strategy. The number of algorithms should be limited. HIV Testing Strategies Parallel and serial testing can be part of any testing strategy. Parallel testing means samples are tested simultaneously by two different tests. Serial testing means samples tested by a first test. The results of the first test determine whether additional testing is required. Testing Algorithms Should be Developed at National Level Before any test is adopted in country for use, a series of key steps must be taken. These steps include: Identifying appropriate tests Developing an algorithm Building consensus Developing policy Bringing into national scale Reviewing testing algorithms annually Because multiple tests are marketed and available in-country, each country must identify the appropriate tests for use within given environment. A standardized approach to developing an algorithm must be taken. This involved building consensus and developing policy before a test is brought to national scale. After testing algorithms are adopted and implemented nationally, these algorithms must be reviewed annually to determine if test are performing as expected, and to determine if any changes need to be made to the algorithm. Timeline for Developing National Testing Algorithm A number of activities must be accomplished before a test is fully implemented. Tests undergo a series of evaluations before they are adopted for use country-wide. The timeline from beginning of evaluation activities to the time when tests are fully implemented is approximately 9 months to 1 year. Module 4: HIV Testing Strategies and Algorithms 2 Participant Manual

Timeline for Developing National Testing Algorithm Phases Key Activities Timelines Project Development Determine Capacity Literature Review Situation Analysis Needs Analysis 1 to 3 months Test Evaluation / Algorithm (Phase I) Proposal Ethical Review Procurement Establish Panels Evaluation Analysis of Data Algorithm Decision Publish Findings 3 to 6 months Development (Phase II) Site Selection Training of Staff On Site Evaluation Algorithm Approval 6 months Monitoring (Phase III) Pilot Manuals Monitor Performance Publish Algorithm > 3 months The test evaluation process includes three phases: Phase I Samples with known HIV results are tested at the laboratory using a number of different kits. The results of the rapid tests are compared with the original laboratory results. Ones that worked the best are then evaluated in phase II. Phase II Clients are tested at a rapid testing site by the tests under evaluation, and the same sample is tested at the laboratory using laboratory tests. The results are compared, and the rapid tests that worked the best will be used in phase III. Phase III Rapid tests that have been approved by the MOH are used at rapid testing sites. Module 4: HIV Testing Strategies and Algorithms 3 Participant Manual

Advantages of National Testing Strategies and Algorithms Nationally adopted testing strategies and algorithms facilitates: Country-level standardization of tests used in country - supporting a limited number of tests is more feasible and practical than many different tests. Procurement and supply management - using standardized tests allows for bulk procurement which facilitates controlling costs. Training Implementation of a national training program is eased when test sites follow the same testing algorithm. This facilitates pre-planning of workshop, as well as assuring staff who move from one test site to another will not require total re-training. Quality Assurance national oversight of quality of testing operations is easier when test sites use the same tests and have similar operations. Key Factors in Determining a Country s Algorithm A number of factors contribute to the selection of specific tests in a country s algorithm. These factors include: test performance in country, test availability in country, program needs, ease of use, type of specimen, cost, and potential need to differentiate between HIV 1 & HIV 2. Evaluating Test Performance: Basic Terms One of the factors that determine a country s algorithm is the performance the tests. This performance is based on how close a test under consideration agrees 100% with the result of another test, i.e., reference method or gold standard, also referred to as the true result or actual HIV status. Sensitivity (Se) and Specificity (Sp) relate to the performance of the test capacity. Sensitivity of a test is its capacity to correctly identify people who are infected with HIV Positive and negative predictive value (PPV & NPV) relate to the probability of the individual being infected or not infected when the test yields a positive or negative result Module 4: HIV Testing Strategies and Algorithms 4 Participant Manual

Calculating Sensitivity, Specificity, PPV & NPV Actual HIV Status (Gold Standard) Total Result HIV Infected HIV Uninfected Total Positive A B A+B Negative C D C+D Total A+C B+D Sensitivity = A (A+C) Specificity = D (B+D) Positive Predictive Value = A (A+B) Negative Predictive Value = D (C+D) This table above provides the formulas for calculating Se, Sp, PPV, & NPV. A = true positives; that is the test under evaluation yields a positive result AND the gold standard (the reference test method used to compare all other test results to) yielded a positive result. C = false negatives; that is the test under evaluation yielded a negative result, while the gold standard or true value was positive. A+C = all people who are truly infected with HIV B = false positives; that is the test under evaluation yields a positive result, while the gold standard or true value was negative D = true negatives; that is the test under evaluation yields a negative result AND the gold standard or true value yielded a negative result B+D = all people who are truly NOT infected with HIV Calculating Sensitivity, Specificity, PPV & NPV (Cont d) Actual HIV Status (Gold Standard) Total Result HIV Infected HIV Uninfected Total Positive A (370) B (2) A+B (372) Negative C (4) D (624) C+D (628) Total A+C (374) B+D (626) 1000 Sensitivity = A (A+C) = 370 374 = 98.9% Specificity = D (B+D) = 624 626 = 99.7% PPV = A (A+B) = 370 372 = 99.5% NPV = D (C+D) = 624 628 = 99.4% The table above illustrates the calculation of Se, Sp, PPV & NPV. Evaluation of a rapid test on a panel of specimens that have been tested by the gold standard to determine actual HIV status is shown to contain HIV antibodies to 374 samples and no HIV antibodies to 626 samples. Module 4: HIV Testing Strategies and Algorithms 5 Participant Manual

Of the 374 serum samples that were antibody positive, the rapid test classified 370 of the samples as positive. Of the 626 samples that were HIV antibody negative by the gold standard, 624 were classified by the rapid tests as not containing HIV antibodies. The results for Se, Sp, PPV, and NPV ranges from 98.9% to 99.7 %. This means: The test performance of the HIV rapid test under evaluation is nearly as good as the results of the gold standard or true value. The HIV test will yield highly accurate results But, while these results indicated very good performance, you must also keep in mind that the performance is influenced by the makeup of the population. HIV Rapid Test Performance As illustrated in the example above, no test is 100% sensitive or 100 % specific when compared to the gold standard. In other words, no test will yield exactly the same result of the gold standard test. How Prevalence Affects PPV & NPV If you know the sensitivity and specificity of the kit and the prevalence of HIV in the population, you can theoretically calculate the predictive value of the performed test. The formula for calculating the predictive values of a test is as follows: (Prevalence) (Se) PPV= (Prevalence) (Se) + (1- Prevalence) (1- Sp) (1-Prevalence) (Sp) NPV= (1-Prevalence) (Sp + (Prevalence) (1- Se) PPV for 10 % prevalence population: (10/100) (98.9/100) = ----------------------------------------------------------------------- = 97.3% (10/100) (98.9/100) + (1-10/100) (1-99.7/100) PPV for 1% prevalence population: (1/100) (98.9/100) = --------------------------------------------------------------------------- = 76.9% (1/100) (98.9/100) + (1-1/100) (1-99.7/100) Module 4: HIV Testing Strategies and Algorithms 6 Participant Manual

In general, the higher the prevalence, the higher the PPV. In this example there is a 97.3 % probability that if a person tests positive then this individual is indeed infected with HIV. Conversely, the lower the prevalence, the lower the PPV. In the example above, there is a 76.9% probability that if a person tests negative, then this individual is indeed not infected with HIV. Testing Algorithm Describes the Sequence of Tests to be Performed Testing Algorithm describes the sequence of tests to be performed. An HIV Positive Status should be based upon the outcome of 2 or more tests. When two test results disagree (one is reactive, the other nonreactive), the finding is called discordant. In this case, a third test must be performed. Always follow the sequence of the tests in the algorithm. Ideal Algorithm The ideal algorithm used in one in which tests are highly sensitive and highly specific. Both tests should not share the same false negatives and false positives, and a third test is performed, if needed. Parallel Testing Algorithm In a parallel testing algorithm, two different tests are performed at the same time. If a 3 rd test or tiebreaker is required, this test is different than test 1 or test 2. Blood Sample Test 1 Test 2 Both Reactive Report Positive Both Non-reactive Report Negative Discordant Result Test 3 Reactive Result Report Positive Non-reactive Result Report Negative Module 4: HIV Testing Strategies and Algorithms 7 Participant Manual

When both tests are reactive, the final HIV result is positive. When both tests are non-reactive, then the final HIV result is negative. If one test is reactive and the other is non-reactive, then a third test known as a tiebreaker is performed. The tie-breaker determines the final result if the tiebreaker is reactive, then the final HIV result is positive; if the tiebreaker is non-reactive, then the final HIV result is negative. The test used as the tiebreaker is a different test than test 1 or 2. Exercises Interpreting HIV Status Using Testing Algorithm At the end of this module, you will find two exercise sheets. Read the instructions and write your answers in the space provided. Possible HIV Test Outcomes: Parallel Testing Algorithm There are a variety of combinations of outcomes when following a parallel testing algorithm. Parallel Testing Algorithm TEST 1 TEST 2 TEST 3 HIV Status Non-reactive Non-reactive Negative Reactive Reactive Positive Non-reactive Reactive Non-reactive Negative Reactive Non-reactive Non-reactive Negative Non-reactive Reactive Reactive Positive Reactive Non-reactive Reactive Positive Key message Before any test is adopted in country for use, a series of key steps must be taken to evaluate the tests before they are fully adopted for use country-wide. The ideal algorithm used in one in which tests are highly sensitive and highly specific. No test is 100% sensitive or 100 % specific when compared to the gold standard. Always follow the sequence of the tests in the algorithm. Module 4: HIV Testing Strategies and Algorithms 8 Participant Manual

Module Review Find out how much you have learned by answering these questions. Explain the importance of a tests: Se, Sp, PPV, NPV - Se - Sp - PPV - NPV Explain the testing algorithm adopted by MOH. What rapid tests are used and in what order? Module 4: HIV Testing Strategies and Algorithms 9 Participant Manual

Exercise #1: Interpreting HIV Status Using Parallel Algorithm A client has come in for an HIV Rapid Test. Following the parallel algorithm, you conducted three tests. The results are shown below. Interpret the HIV Rapid Test results for Test #1, Test #2, and Test #3 Decide HIV Status Test #1 Test #2 Test #3 Result: Result: Result: Final HIV Status Module 4: HIV Testing Strategies and Algorithms 11 Participant Manual

Exercise #2: Interpreting HIV Status Using Serial Algorithm A client came in for an HIV Rapid Test. Following the serial algorithm, you conducted two tests. The results are shown below. Interpret the HIV Rapid Test results for Test #1 and Test #2. Decide if a third test is needed. If not, what is the client s HIV status? Test #1 Test #2 Result: Result: Is a third test needed? Yes No If no, what is the HIV Status? Module 4: HIV Testing Strategies and Algorithms 12 Participant Manual